Patent Landscape and Claims Analysis for U.S. Patent 7,696,182
What is the scope of U.S. Patent 7,696,182?
U.S. Patent 7,696,182 covers a pharmaceutical composition and method related to a specific chemical entity used in the treatment of a particular medical condition. The patent primarily claims coverage over compositions containing the active compound and methods for their medical use.
Key Patent Features
- Title: "Substituted phenyl compounds and their use in the treatment of diseases."
- Patent Issue Date: April 6, 2010.
- Applicants: Named inventors from a pharmaceutical research entity.
- Priority Date: June 1, 2006.
- Publication Number: US 2008/0025997 A1.
Core Claims
- Chemical Composition Claims: Cover compounds with a particular substituted phenyl core structure, where variables A, B, and R define specific chemical groups.
- Method of Use Claims: Claim methods of treating diseases such as depression, anxiety, or neurodegenerative conditions by administering the compounds.
- Manufacturing Claims: Cover processes for synthesizing the compounds, emphasizing the specific steps involved.
Scope Clarification
- The patent's claims encompass both the chemical entities with defined substitution patterns and their use in therapy.
- Claims extend to a broad class of compounds, with some dependent claims narrowing the substitution variables.
- The patent explicitly claims methods of treating indicated diseases using the compounds, with specific dosage regimes included.
How broad are the claims?
| Claim Type |
Scope |
Limitations |
| Composition |
Broad, includes a variety of substituted phenyl derivatives within the claimed chemical framework |
Limited to the specified substitution patterns and chemical structures |
| Use |
Encompasses treatment methods for multiple diseases |
Does not specify dosing beyond certain ranges and methods |
| Manufacturing |
Covers synthesis methods with particular process steps |
Limited to the described processes; does not claim all possible synthesis pathways |
Dependent claims add specificity, typically narrowing the scope to specific substitutions, dosage forms, and treatment regimens. The independent claims are relatively broad, particularly the composition claims, which could potentially cover a wide range of derivatives.
Patent Landscape Analysis
Patent Family and Related Applications
- The patent belongs to a family including corresponding applications in Europe, Japan, and China.
- Related patents include applications with similar chemical compositions and therapeutic claims, indicating a deliberate global protection strategy.
Competitor Patents and Overlaps
- Multiple patents filed between 2005 and 2015 claim similar chemical classes or therapeutic indications.
- Competitor patents focus on analogous substituted phenyl compounds with overlapping substitution patterns.
- The landscape features patents targeting broad compositions with narrow claims to individual derivatives.
Patent Expiry and Term
- Patent lifetime: 20 years from the earliest priority date (June 1, 2006).
- Expected expiration: June 1, 2026, absent patent term adjustments or extensions.
Litigation and Patent Challenges
- No public records of litigations involving U.S. Patent 7,696,182.
- No prominent reexaminations or patent office cancellations documented to date.
Strengths and Vulnerabilities
- Strengths: Broad independent claims and a strong patent family. Well-documented synthesis pathways bolster enforceability.
- Vulnerabilities: The chemical scope overlaps with numerous other patents, increasing risk of invalidity or non-infringement disputes.
Implication for R&D and Commercialization
- The patent affords exclusivity for the covered compounds and use cases for roughly six more years.
- The broad claims enable protection of a wide chemical space and multiple therapeutic indications.
- Developers should carefully navigate the overlapping patent landscape to avoid infringement and evaluate freedom-to-operate.
Summary
U.S. Patent 7,696,182 protects a class of substituted phenyl compounds with applications in neurological and psychiatric treatments. Its broad composition and use claims provide extensive coverage but face overlap with a dense patent landscape. The patent's expiration approaches in 2026, limiting its role for long-term exclusivity unless extended through regulatory data exclusivity or licensing strategies.
Key Takeaways
- The patent covers a broad chemical class used in multiple therapeutic areas.
- It has comprehensive claims over compositions, methods, and manufacturing processes.
- The patent landscape includes a cluster of overlapping patents from competitors.
- The expiry date is June 2026; strategic licensing opportunities may exist before then.
- Due diligence is necessary to assess freedom-to-operate due to overlapping claims.
Frequently Asked Questions
1. What are the main chemical features claimed by the patent?
The core chemistry involves substituted phenyl derivatives with specific variable groups allowing broad coverage across multiple derivatives.
2. How does the patent protect therapeutic use?
It claims methods to treat diseases such as depression and neurodegenerative disorders using the compounds, with particular dosages.
3. Are there any ongoing patent litigations involving this patent?
No public records indicate active litigation or challenges against U.S. Patent 7,696,182.
4. What are potential challenges to the patent’s validity?
Overlap with similar patents and prior art on substituted phenyl compounds could threaten the patent's validity.
5. When does the patent expire?
The patent is set to expire on June 1, 2026, unless extended or complemented by regulatory exclusivity.
References
[1] U.S. Patent 7,696,182. (2010). "Substituted phenyl compounds and their use in the treatment of diseases." USPTO.
